Regal Partners Ltd Has $11.82 Million Holdings in Core Scientific, Inc. (NASDAQ:CORZ)

Regal Partners Ltd grew its holdings in Core Scientific, Inc. (NASDAQ:CORZ) by 71.5% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 996,551 shares of the company’s stock after buying an additional 415,363 shares during the quarter. Core Scientific accounts for approximately 1.0% of Regal Partners Ltd’s holdings, making the stock its 27th biggest holding. Regal Partners Ltd’s holdings in Core Scientific were worth $11,819,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. ORG Wealth Partners LLC bought a new position in shares of Core Scientific during the 3rd quarter worth about $106,266,000. Vanguard Group Inc. bought a new position in shares of Core Scientific during the 1st quarter worth about $21,973,000. Kensico Capital Management Corp bought a new position in shares of Core Scientific during the 1st quarter worth about $18,513,000. Van ECK Associates Corp lifted its holdings in shares of Core Scientific by 22.9% during the 3rd quarter. Van ECK Associates Corp now owns 1,616,944 shares of the company’s stock worth $19,177,000 after acquiring an additional 300,942 shares during the period. Finally, Vident Advisory LLC bought a new position in Core Scientific during the 1st quarter valued at about $4,047,000.

Core Scientific Price Performance

Shares of NASDAQ:CORZ opened at $16.13 on Thursday. Core Scientific, Inc. has a one year low of $2.61 and a one year high of $18.03. The company has a 50 day moving average of $12.76 and a 200-day moving average of $9.72. The stock has a market cap of $4.50 billion and a price-to-earnings ratio of -2.98.

Insider Transactions at Core Scientific

In related news, CFO Denise Marie Brucia Sterling sold 8,752 shares of Core Scientific stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $9.41, for a total transaction of $82,356.32. Following the transaction, the chief financial officer now owns 122,217 shares of the company’s stock, valued at $1,150,061.97. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other Core Scientific news, CFO Denise Marie Brucia Sterling sold 8,752 shares of Core Scientific stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $9.41, for a total value of $82,356.32. Following the transaction, the chief financial officer now owns 122,217 shares of the company’s stock, valued at approximately $1,150,061.97. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Todd M. Duchene sold 11,582 shares of Core Scientific stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $9.41, for a total transaction of $108,986.62. Following the completion of the transaction, the insider now directly owns 1,686,474 shares in the company, valued at approximately $15,869,720.34. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders acquired a total of 12,761 shares of company stock worth $127,080 in the last quarter. 32.00% of the stock is owned by company insiders.

Analyst Ratings Changes

CORZ has been the subject of several analyst reports. Canaccord Genuity Group reissued a “buy” rating and set a $17.00 price target on shares of Core Scientific in a report on Thursday, November 7th. Cantor Fitzgerald reissued an “overweight” rating and set a $20.00 price target on shares of Core Scientific in a report on Thursday, October 3rd. HC Wainwright lifted their price target on shares of Core Scientific from $15.00 to $17.00 and gave the company a “buy” rating in a report on Thursday, November 7th. Canaccord Genuity Group initiated coverage on shares of Core Scientific in a report on Monday, September 23rd. They set a “buy” rating and a $16.00 price target for the company. Finally, B. Riley lifted their price target on shares of Core Scientific from $16.00 to $17.00 and gave the company a “buy” rating in a report on Thursday, November 7th. Twelve research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $17.21.

Core Scientific Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.